{
    "organizations": [],
    "uuid": "8d8981053a6979922e29834dee98a3becc78e009",
    "author": "",
    "url": "https://www.reuters.com/article/brief-eyenovia-sees-ipo-of-273-mln-share/brief-eyenovia-sees-ipo-of-2-73-mln-shares-of-common-stock-priced-between-10-12-per-share-idUSFWN1P40GU",
    "ord_in_thread": 0,
    "title": "BRIEF-Eyenovia Sees IPO Of 2.73 Mln Shares Of Common Stock Priced Between $10-$12 Per Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 12 PM / in 9 minutes BRIEF-Eyenovia Sees IPO Of 2.73 Mln Shares Of Common Stock Priced Between $10-$12 Per Share Reuters Staff 1 Min Read \nJan 9 (Reuters) - Eyenovia Inc: \n* EYENOVIA INC SEES IPO OF 2.73 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $10.00 AND $12.00 PER SHARE - SEC FILING \n* EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $12 MILLION TO COMPLETE PHASE III CLINICAL TRIALS FOR MICROPROST \n* EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $2 MILLION TO COMPLETE PHASE III CLINICAL TRIALS FOR MICROSTAT \n* EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $1.5 MILLION TO COMPLETE MICROTEARS REGISTRATION ACTIVITIES Source: ( bit.ly/2EoBYr8 ) Further company coverage:",
    "published": "2018-01-09T14:12:00.000+02:00",
    "crawled": "2018-01-09T14:33:07.021+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "see",
        "ipo",
        "mln",
        "share",
        "common",
        "stock",
        "priced",
        "per",
        "share",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "eyenovia",
        "inc",
        "eyenovia",
        "inc",
        "see",
        "ipo",
        "million",
        "share",
        "common",
        "stock",
        "priced",
        "per",
        "share",
        "sec",
        "filing",
        "eyenovia",
        "say",
        "intends",
        "use",
        "ipo",
        "proceeds",
        "together",
        "existing",
        "cash",
        "million",
        "complete",
        "phase",
        "iii",
        "clinical",
        "trial",
        "microprost",
        "eyenovia",
        "say",
        "intends",
        "use",
        "ipo",
        "proceeds",
        "together",
        "existing",
        "cash",
        "million",
        "complete",
        "phase",
        "iii",
        "clinical",
        "trial",
        "microstat",
        "eyenovia",
        "say",
        "intends",
        "use",
        "ipo",
        "proceeds",
        "together",
        "existing",
        "cash",
        "million",
        "complete",
        "microtears",
        "registration",
        "activity",
        "source",
        "company",
        "coverage"
    ]
}